The Impact of COVID-19 is included in Toxoid Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Toxoid Vaccine Trends and Forecast
The future of the global toxoid vaccine market looks promising with opportunities in the hospital, specialty centre, and government organization markets. The global toxoid vaccine market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, augmenting demand for vaccination in developing countries, and supportive initiatives by the government to encourage immunization.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Toxoid Vaccine by Segment
The study includes a forecast for the global toxoid vaccine by vaccine type, end use, and region.
Toxoid Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:
• Diphtheria, Tetanus, and Pertussis (DTaP)
• Diphtheria and Tetanus (DT)
• Tetanus, Diphtheria, and Pertussis (TDaP)
• Others
Toxoid Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Specialty Centre
• Governments Organization
• Others
Toxoid Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Toxoid Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies toxoid vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the toxoid vaccine companies profiled in this report include-
• Bharat Biotech
• Ceva
• Glaxosmithkline
• Grifols
• Zoetis
• Sanofi
• Merck & Co
• Emergent Biosolutions
• Integrated Biotherapeutics
• Abbott
Toxoid Vaccine Market Insights
Lucintel forecasts that DTaP is expected to witness highest growth over the forecast period due to its growing usage among children to protect against the dangerous illnesses diphtheria, tetanus, and pertussis.
Within this market, hospital is expected to witness highest growth over the forecast period due to the growing number of toxoid vaccinations is given out in hospitals, particularly to infants and pregnant women.
APAC is expected to witness highest growth over the forecast period due to the rapid population growth and the rising cases of infectious illnesses among people of the region.
Features of the Global Toxoid Vaccine Market
Market Size Estimates: Toxoid vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Toxoid vaccine market size by vaccine type, end use, and region in terms of value ($B).
Regional Analysis: Toxoid vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different vaccine types, end uses, and regions for the toxoid vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the toxoid vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the toxoid vaccine market size?
Answer: The global toxoid vaccine market is expected to reach an estimated $7.5 billion by 2030.
Q.2 What is the growth forecast for toxoid vaccine market?
Answer: The global toxoid vaccine market is expected to grow with a CAGR of 4.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the toxoid vaccine market?
Answer: The major drivers for this market are rising prevalence of infectious diseases, augmenting demand for vaccination in developing countries and, supportive initiatives by the government to encourage immunization.
Q4. What are the major segments for toxoid vaccine market?
Answer: The future of the toxoid vaccine market looks promising with opportunities in the hospital, specialty centre, and government organization markets.
Q5. Who are the key toxoid vaccine market companies?
Answer: Some of the key toxoid vaccine companies are as follows:
• Bharat Biotech
• Ceva
• Glaxosmithkline
• Grifols
• Zoetis
• Sanofi
• Merck & Co
• Emergent Biosolutions
• Integrated Biotherapeutics
• Abbott
Q6. Which toxoid vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that DTaP is expected to witness highest growth over the forecast period due to its growing usage among children to protect against the dangerous illnesses diphtheria, tetanus, and pertussis.
Q7. In toxoid vaccine market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to the rapid population growth and the rising cases of infectious illnesses among people of the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the toxoid vaccine market by vaccine type (diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), tetanus, diphtheria, and pertussis (TDaP), and others), end use (hospitals, specialty centre, governments organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to toxoid vaccine market or related to toxoid vaccine companies, toxoid vaccine market size, toxoid vaccine market share, toxoid vaccine market growth, toxoid vaccine market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Toxoid Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Toxoid Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Toxoid Vaccine Market by Vaccine Type
3.3.1: Diphtheria, Tetanus, and Pertussis (DTaP)
3.3.2: Diphtheria and Tetanus (DT)
3.3.3: Tetanus, Diphtheria, and Pertussis (TDaP)
3.3.4: Others
3.4: Global Toxoid Vaccine Market by End Use
3.4.1: Hospitals
3.4.2: Specialty Centre
3.4.3: Governments Organization
3.4.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Toxoid Vaccine Market by Region
4.2: North American Toxoid Vaccine Market
4.2.2: North American Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others
4.3: European Toxoid Vaccine Market
4.3.1: European Toxoid Vaccine Market by Vaccine Type: Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (TDaP), and Others
4.3.2: European Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others
4.4: APAC Toxoid Vaccine Market
4.4.1: APAC Toxoid Vaccine Market by Vaccine Type: Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (TDaP), and Others
4.4.2: APAC Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others
4.5: ROW Toxoid Vaccine Market
4.5.1: ROW Toxoid Vaccine Market by Vaccine Type: Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (TDaP), and Others
4.5.2: ROW Toxoid Vaccine Market by End Use: Hospitals, Specialty Centre, Governments Organization, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Toxoid Vaccine Market by Vaccine Type
6.1.2: Growth Opportunities for the Global Toxoid Vaccine Market by End Use
6.1.3: Growth Opportunities for the Global Toxoid Vaccine Market by Region
6.2: Emerging Trends in the Global Toxoid Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Toxoid Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Toxoid Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Bharat Biotech
7.2: Ceva
7.3: GlaxoSmithKline
7.4: Grifols
7.5: Zoetis
7.6: Sanofi
7.7: Merck & Co
7.8: Emergent BioSolutions
7.9: Integrated BioTherapeutics
7.10: Abbott
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Toxoid Vaccine Market Report.